Traduction de «million for the second quarter » (Néerlandais → Français) :

Operating income Operating loss was USD 42 million for the second quarter of 2010 (+72% cc) compared to a USD 167 million loss for the second quarter of 2009, improved by the strong sales performance.
Résultat opérationnel Au deuxième trimestre 2010, la perte opérationnelle s’est élevée à USD 42 millions (+72% tcc), contre USD 167 millions au deuxième trimestre 2009.

The operating income margin of 31.2% of net sales was impacted by litigation charges of USD 178 million in the second quarter, and in the first quarter by a PTZ601 impairment charge of USD 152 million, in addition to the Famvir settlement with Teva which included an asset write-up of USD 100 million and an exceptional settlement gain of USD 42 million.
La marge opérationnelle de 31.2% du chiffre d’affaires net a subi l’impact de charges pour litiges et règlements juridiques d’USD 178 millions au deuxième trimestre et d’une charge d’USD 152 millions pour perte de valeur concernant PTZ601 au premier trimestre. Un règlement conclu avec Teva au sujet de Famvir s’est traduit par la réévaluation d’un actif à hauteur d’USD 100 millions et par un dédommagement d’USD 42 millions en notre faveur.

Vaccines and Diagnostics: USD –167 million Excluding exceptional items and amortization of intangible assets, the adjusted operating loss was USD 46 million in the second quarter of 2009 compared to adjusted operating income of USD 16 million in the 2008 period.
Vaccins et Diagnostic: USD –167 millions Hors éléments exceptionnels et amortissement d’immobilisations incorporelles, la perte opérationnelle ajustée s’est élevée à USD 46 millions au deuxième trimestre 2009, contre un bénéfice opérationnel ajusté d’USD 16 millions au deuxième trimestre 2008.

The accounting consequence of this change in the Swiss pension plan rules results in the Group’s consolidated financial statements prepared under IFRS reflecting a net pre-tax curtailment gain of USD 265 million (CHF 283 million) in the second quarter of 2010.
Sur le plan comptable, ce changement du régime des retraites en Suisse a entraîné un gain lié aux modifications de la comptabilisation du régime de retraites d’USD 265 millions (CHF 283 millions) avant impôts reflété dans les comptes consolidés du Groupe préparés selon les normes IFRS au deuxième trimestre 2010.

Net sales Net sales were USD 564 million for the second quarter (+135% cc) compared with USD 247 million in the prior period.
Chiffre d’affaires net Au deuxième trimestre, le chiffre d’affaires net s’est élevé à USD 564 millions (+135% tcc), contre USD 247 millions un an auparavant.

Income from associated companies The increase in income from associated companies of 27% to USD 158 million in the second quarter of 2010 was primarily driven by higher net income contribution from the Alcon investment.
Quote-part dans le résultat net des entreprises associées Au deuxième trimestre 2010, l’augmentation de la quote-part dans le résultat net des entreprises associées de 27% à USD 158 millions est due essentiellement à la hausse de la contribution au résultat net provenant de l'investissement dans Alcon.

1 Full-year net sales in 2008 include a one-time contribution of USD 104 million in the second quarter of 2008. These brand-specific provision reversals were made following a Novartis review of accounting for rebate programs to US government health agencies.
reprise d’une provision à la suite d’une révision par Novartis des programmes de rabais accordés aux agences nationales de santé des Etats-Unis.

To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com and click on the “Pfizer Quarterly Corporate Performance – Second Quarter 2010” link in the Investor Presentations tab on our homepage.
To view and listen to the webcast, visit our web site at www.pfizer.com and click on the “2010 Annual Credit Suisse Healthcare Conference” link in the Investor Presentations section located on the lower right-hand corner of that page.

Pfizer Hosts Annual Meeting Of Shareholders Declares 22-Cent Second-Quarter 2012 Dividend
Pfizer Invites Public To Listen To Webcast Of April 26 Annual Meeting Of Shareholders

31-okt-2013 Bayer continues positive business momentum Ongoing dynamic trend in Life Sciences; MaterialScience level with prior-year quarter / New pharmaceutical products post excellent growth / Group sales EUR 9,643 million (minus 0.2 percent; Fx & portfolio adj. plus 6.0 percent) / EBIT shows 47.5 percent improvement to EUR 1,221 million / EBITDA before special items moves 7.7 percent higher to EUR 1,984 million / Net income advances by 42.1 percent to EUR 733 million / Core earnings per share up 8.5 percent to EUR 1.27 / Group guidance for 2013 maintained » meer
31-oct.-2013 Bayer continues positive business momentum Ongoing dynamic trend in Life Sciences; MaterialScience level with prior-year quarter / New pharmaceutical products post excellent growth / Group sales EUR 9,643 million (minus 0.2 percent; Fx & portfolio adj. plus 6.0 percent) / EBIT shows 47.5 percent improvement to EUR 1,221 million / EBITDA before special items moves 7.7 percent higher to EUR 1,984 million / Net income advances by 42.1 percent to EUR 733 million / Core earnings per share up 8.5 percent to EUR 1.27 / Group guidance for 2013 maintained » En savoir plus